nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response
|
Sflomos, George |
|
2016 |
29 |
3 |
p. 407-422 |
artikel |
2 |
A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity
|
Jing, Hui |
|
2016 |
29 |
3 |
p. 297-310 |
artikel |
3 |
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
|
Johann, Pascal D. |
|
2016 |
29 |
3 |
p. 379-393 |
artikel |
4 |
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2+ Breast Cancer
|
Malumbres, Marcos |
|
2016 |
29 |
3 |
p. 243-244 |
artikel |
5 |
Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
|
Tang, Haidong |
|
2016 |
29 |
3 |
p. 285-296 |
artikel |
6 |
Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways
|
Chun, Hye-Jung E. |
|
2016 |
29 |
3 |
p. 394-406 |
artikel |
7 |
HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma
|
Pei, Yanxin |
|
2016 |
29 |
3 |
p. 311-323 |
artikel |
8 |
HIV Drug to Aid Melanoma Therapies?
|
Kim, Hyungsoo |
|
2016 |
29 |
3 |
p. 245-246 |
artikel |
9 |
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
|
Smith, Michael P. |
|
2016 |
29 |
3 |
p. 270-284 |
artikel |
10 |
KLF4 Initiates Acinar Cell Reprogramming and Is Essential for the Early Stages of Pancreatic Carcinogenesis
|
Maddipati, Ravikanth |
|
2016 |
29 |
3 |
p. 247-248 |
artikel |
11 |
KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis
|
Wei, Daoyan |
|
2016 |
29 |
3 |
p. 324-338 |
artikel |
12 |
Mammary Ductal Environment Is Necessary for Faithful Maintenance of Estrogen Signaling in ER+ Breast Cancer
|
Haricharan, Svasti |
|
2016 |
29 |
3 |
p. 249-250 |
artikel |
13 |
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
|
Goel, Shom |
|
2016 |
29 |
3 |
p. 255-269 |
artikel |
14 |
PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion
|
Halberg, Nils |
|
2016 |
29 |
3 |
p. 339-353 |
artikel |
15 |
Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma
|
Ali, Syed A. |
|
2016 |
29 |
3 |
p. 367-378 |
artikel |
16 |
Selective Targeting of the KRAS G12C Mutant: Kicking KRAS When It’s Down
|
Hobbs, G. Aaron |
|
2016 |
29 |
3 |
p. 251-253 |
artikel |
17 |
Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development
|
Sarris, Michalis E. |
|
2016 |
29 |
3 |
p. 354-366 |
artikel |